Clinical Trial Update: S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating S-1 plus cisplatin in patients undergoing surgery for stage III gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Platinol (cisplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Kyoto University | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED